NextPlat (NASDAQ:NXPL) Issues Quarterly Earnings Results, Beats Estimates By $0.16 EPS

NextPlat (NASDAQ:NXPLGet Free Report) announced its earnings results on Thursday. The company reported ($0.05) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.21) by $0.16, Zacks reports. NextPlat had a negative return on equity of 58.05% and a negative net margin of 23.14%.

NextPlat Stock Performance

Shares of NextPlat stock traded up $1.06 during trading on Thursday, reaching $7.77. The company’s stock had a trading volume of 92,972 shares, compared to its average volume of 71,517. The company has a current ratio of 2.56, a quick ratio of 2.12 and a debt-to-equity ratio of 0.05. The firm has a market cap of $21.04 million, a PE ratio of -1.84 and a beta of 1.83. NextPlat has a fifty-two week low of $3.38 and a fifty-two week high of $11.10. The company has a 50-day moving average price of $6.37 and a two-hundred day moving average price of $5.95.

Hedge Funds Weigh In On NextPlat

A hedge fund recently bought a new stake in NextPlat stock. Citadel Advisors LLC bought a new stake in NextPlat Corp. (NASDAQ:NXPLFree Report) in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 48,176 shares of the company’s stock, valued at approximately $40,000. Citadel Advisors LLC owned approximately 0.19% of NextPlat at the end of the most recent quarter. 1.30% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of brokerages have recently weighed in on NXPL. Weiss Ratings restated a “sell (d-)” rating on shares of NextPlat in a research note on Friday, August 7th. Zacks Research upgraded shares of NextPlat to a “hold” rating in a research report on Thursday, June 25th. Finally, Litchfield Hills Research initiated coverage on NextPlat in a research note on Wednesday, June 24th. They set a “buy” rating and a $11.00 price objective for the company. One research analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $11.00.

View Our Latest Analysis on NXPL

NextPlat Company Profile

(Get Free Report)

NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa. The company operates full-service retail specialty services pharmacies that provides prescription pharmaceuticals prescription pharmaceuticals, third-party administration, risk and data management services, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, contracted pharmacy services, and health practice risk management to healthcare organizations and providers, as well as supplies prescription medications to long-term care facilities.

Further Reading

Earnings History for NextPlat (NASDAQ:NXPL)

Receive News & Ratings for NextPlat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NextPlat and related companies with MarketBeat.com's FREE daily email newsletter.